A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway (Q43635201)

From Wikidata
Jump to navigation Jump to search
scientific article published in July 2008
edit
Language Label Description Also known as
English
A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway
scientific article published in July 2008

    Statements

    A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway (English)
    Zohar Tiran
    Anat Oren
    Chen Hermesh
    Galit Rotman
    Zurit Levine
    Hagit Amitai
    Tal Handelsman
    Merav Beiman
    Aviva Chen
    Dalit Landesman-Milo
    Liat Dassa
    Yair Peres
    Cynthia Koifman
    Sarit Glezer
    Rinat Vidal-Finkelstein
    Kobi Bahat
    Tania Pergam
    Cylia Israel
    Judith Horev
    Michal Ayalon-Soffer
    1 July 2008
    4612-4621

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit